You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 20, 2024

CLINICAL TRIALS PROFILE FOR ALESSE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for ALESSE

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00315107 ↗	Estrogen Treatment in Acromegalic Women	Unknown status	Novartis	Phase 2	2006-05-01	Oral estrogens may be an effective adjuvant treatment for control of acromegaly in patients with resistance to somatostatin analogs.
NCT00315107 ↗	Estrogen Treatment in Acromegalic Women	Unknown status	Université de Montréal	Phase 2	2006-05-01	Oral estrogens may be an effective adjuvant treatment for control of acromegaly in patients with resistance to somatostatin analogs.
NCT00481650 ↗	Observational Trial With Leios/Alesse	Completed	Wyeth is now a wholly owned subsidiary of Pfizer		2005-05-01	A prospective, observational study (Anwendungsbeobachtung [AWB]) of the prescribing and administration practices of German gynecologists with Leios® Dragées.
NCT00662454 ↗	Oral Contraceptive Efficacy and Body Weight	Completed	National Institutes of Health (NIH)	Phase 4	2006-01-01	The purpose of the blood spot validation portion of the study is to test if measuring female hormone levels in the blood is as accurate through a finger stick, as it is by a blood draw from a vein. The purpose of the feasibility study is to evaluate ovulation occurrence in two populations of oral contraceptive users: heavier and lighter women.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for ALESSE

Condition Name

Chart
Table

Condition Name for ALESSE
Intervention	Trials
Acromegaly	1
Body Weight	1
Contraception	1
Contraceptives, Oral, Combined	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for ALESSE
Intervention	Trials
Body Weight	1
Acromegaly	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for ALESSE

Trials by Country

Map
Table

Trials by Country for ALESSE
Location	Trials
Canada	1
United States	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for ALESSE
Location	Trials
Oregon	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for ALESSE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for ALESSE
Clinical Trial Phase	Trials
Phase 4	1
Phase 2	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for ALESSE
Clinical Trial Phase	Trials
Completed	2
Unknown status	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ALESSE

Sponsor Name

Chart
Table

Sponsor Name for ALESSE
Sponsor	Trials
Novartis	1
Université de Montréal	1
Wyeth is now a wholly owned subsidiary of Pfizer	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for ALESSE
Sponsor	Trials
Other	3
Industry	2
NIH	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.